Lewis H. Silver

1.2k total citations
16 papers, 902 citations indexed

About

Lewis H. Silver is a scholar working on Ophthalmology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Lewis H. Silver has authored 16 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Ophthalmology, 6 papers in Pathology and Forensic Medicine and 5 papers in Physiology. Recurrent topics in Lewis H. Silver's work include Glaucoma and retinal disorders (9 papers), Ophthalmology and Eye Disorders (6 papers) and Ocular Surface and Contact Lens (4 papers). Lewis H. Silver is often cited by papers focused on Glaucoma and retinal disorders (9 papers), Ophthalmology and Eye Disorders (6 papers) and Ocular Surface and Contact Lens (4 papers). Lewis H. Silver collaborates with scholars based in United States. Lewis H. Silver's co-authors include Alan L. Weiner, Alberta A. Davis, Theresa Landry, Emily Sullivan, Michael V.W. Bergamini, S.M. Robertson, Russell Andrew, Peter A. Netland, Jaime E. Dickerson and Sushanta Mallick and has published in prestigious journals such as The American Journal of Medicine, Journal of Neurochemistry and Ophthalmology.

In The Last Decade

Lewis H. Silver

16 papers receiving 848 citations

Peers

Lewis H. Silver
Andrew de Roetth United States
Jonas S. Friedenwald United States
E. Padillo United States
Clive L. Cornell United States
Hans Fliri Austria
J Obenberger Czechia
Lewis H. Silver
Citations per year, relative to Lewis H. Silver Lewis H. Silver (= 1×) peers Kouichi Kawazu

Countries citing papers authored by Lewis H. Silver

Since Specialization
Citations

This map shows the geographic impact of Lewis H. Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis H. Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis H. Silver more than expected).

Fields of papers citing papers by Lewis H. Silver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis H. Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis H. Silver. The network helps show where Lewis H. Silver may publish in the future.

Co-authorship network of co-authors of Lewis H. Silver

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis H. Silver. A scholar is included among the top collaborators of Lewis H. Silver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis H. Silver. Lewis H. Silver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Whitson, Jess T., Marlene R. Moster, Emily Sullivan, et al.. (2006). The Safety and Intraocular Pressure–Lowering Efficacy of Brimonidine Tartrate 0.15% Preserved with Polyquaternium-1. Ophthalmology. 113(8). 1333–1339. 20 indexed citations
2.
Meltzer, Eli O., Frank C. Hampel, Paul H. Ratner, et al.. (2005). Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Annals of Allergy Asthma & Immunology. 95(6). 600–606. 37 indexed citations
3.
Ratner, Paul H., Frank C. Hampel, Niran J. Amar, et al.. (2005). Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar. Annals of Allergy Asthma & Immunology. 95(5). 474–479. 33 indexed citations
4.
Silver, Lewis H., et al.. (2005). Clinical Safety of Moxifloxacin Ophthalmic Solution 0.5% (VIGAMOX®) in Pediatric and Nonpediatric Patients With Bacterial Conjunctivitis. Survey of Ophthalmology. 50(6). S55–S63. 23 indexed citations
5.
Dubiner, Harvey, Theresa Landry, Michael V.W. Bergamini, et al.. (2004). Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure. Clinical Therapeutics. 26(1). 84–91. 74 indexed citations
6.
Netland, Peter A., S.M. Robertson, Emily Sullivan, et al.. (2003). Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension. Advances in Therapy. 20(3). 149–163. 32 indexed citations
7.
Fellman, Ronald L., Emily Sullivan, Lewis H. Silver, et al.. (2002). Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure. Ophthalmology. 109(5). 998–1008. 80 indexed citations
8.
Netland, Peter A., Theresa Landry, Russell Andrew, et al.. (2002). Author reply. American Journal of Ophthalmology. 133(5). 732–733. 3 indexed citations
9.
Orengo-Nania, Silvia, Theresa Landry, Mark Von Tress, et al.. (2001). Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%. American Journal of Ophthalmology. 132(6). 860–868. 46 indexed citations
10.
Netland, Peter A., Theresa Landry, Emily Sullivan, et al.. (2001). Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. American Journal of Ophthalmology. 132(4). 472–484. 335 indexed citations
11.
Silver, Lewis H., et al.. (2000). Long-term intraocular pressure–lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with timoptic XE 0.5% in a 12-month study. American Journal of Ophthalmology. 130(2). 145–150. 24 indexed citations
12.
Silver, Lewis H.. (1998). Clinical efficacy and safety of brinzolamide (Azopt™), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. American Journal of Ophthalmology. 126(3). 400–408. 159 indexed citations
13.
Singleton, W. S., et al.. (1989). Efficacy and safety of Minipress XL, a new once-a-day formulation of prazosin. The American Journal of Medicine. 87(2). S45–S52. 5 indexed citations
14.
Silver, Lewis H. & Steven R. Houser. (1985). Decreased sodium-potassium pump activity in isolated hypertrophied feline ventricular myocytes. Life Sciences. 37(7). 607–615. 7 indexed citations
15.
Silver, Lewis H. & Steven N. Treistman. (1982). Effects of alcohols upon pacemaker activity in neurons ofAplysia californica. Cellular and Molecular Neurobiology. 2(3). 215–226. 12 indexed citations
16.
Silver, Lewis H. & David J. Prescott. (1982). Aggregation Properties of the Acetylcholinesterase from the Central Nervous System of Manduca sexta. Journal of Neurochemistry. 38(6). 1709–1718. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026